Cristina Delgado

Scientific Committee · International Collaborations Department

Cristina graduated in Pharmacy for the Universidad de Alcalá de Henares in 1981 and received the Prize “Jose Lucas Gallego” from La Real Academia de Farmacia in January 1982. She joined the Department of Biochemistry to undertake research studies on the properties of glucose-6-phosphate dehydrogenase throughout the differentiation of red blood cells. Her MPhil and a PhD were obtained in 1983 and 1986 and were awarded Prizes by the Consejo General de Colegios de Farmacia in 1984 and Real Academia de Farmacia (Premio Ascension Vidal) in 1987, respectively. During her first post-doctoral position at the Royal Free Hospital Medical School (now part of UCL), Cristina was the principal investigator in the development of new technologies for the PEGylation of proteins, liposomes and viruses which innovation lead to seven patent families. In order to commercialise the technology, in 1995 Cristina together with Drs Gillian Francis and Derek Fisher founded PolyMASC Pharmaceuticals plc, the first biotechnology start-up in England to get the initial funding via a flotation in AIM of the London Stock Exchange. She continued her scientific career as Director of Pharmacological Research contributing to the development of the technology in the laboratory (implementing SOPs, developing scale-up, etc) and also the strategic development of the patent portfolio to maximise commercial success. In 1999, Cristina played a pivotal role during the sale of PolyMASC to Valentis Inc, a biotech located in Burlingame near San Francisco. After completing the successful transfer of the technology to California in 2001, Cristina has continued her scientific activity in the United Kingdom as an independent consultant in various projects for biotech companies and also as an expert witness in litigations between pharmaceutical companies.